Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.


Overview | Financials
Company Name Eledon Pharmaceuticals, Inc.
Symbol ELDN
Currency USD
Price 2.4
Market Cap 58,075,440
Dividend Yield 0%
52-week-range 1.07 - 3.349
Industry Biotechnology
Sector Healthcare
CEO Dr. David-Alexandre C. Gros M.D., Ph.D.
Website https://eledon.com

An error occurred while fetching data.

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on

Related Stocks

Eargo, Inc. logo

Eargo, Inc.


2.57 USD

Aquestive Therapeutics, Inc. logo

Aquestive Therapeutics, Inc.


3.07 USD

NexImmune, Inc. logo

NexImmune, Inc.


3.11 USD

STRATA Skin Sciences, Inc. logo

STRATA Skin Sciences, Inc.


0.38 USD

Alimera Sciences, Inc. logo

Alimera Sciences, Inc.


3.14 USD


Numbers are in millions USD

Numbers are in millions USD